2741
|
|
|
Canopy FGF signaling regulator 3 |
CAG4A, DEE60, EIEE60, ERDA5, PRAT4A, TNRC5 |
|
2742
|
|
|
- |
- |
|
2743
|
|
|
Canopy FGF signaling regulator 4 |
PRAT4B |
|
2744
|
|
|
Cannabinoid receptor 1 |
CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR |
Anxiety disorder, Attention deficit hyperactivity disorder, Binge eating disorder, Bipolar disorder, Cannabis abuse, Catalepsy, Cholelithiasis, Cognition disorder, Conduct disorder, Delirium, dementia, and cognitive disorders, Major depressive disorder, Developmental coordination disorder, Diabetes mellitus type 2, Endometrial neoplasms, Endometriosis, Temporal lobe epilepsy, Huntington disease, Hyperalgesia, Hypotension, Liver cirrhosis, Lung cancer, Melanoma, Memory disorders, Motor skills disorder, Movement disorder, Multiple sclerosis, Obesity, Pancreatic neoplasms, Pancreatitis, Post-traumatic stress disorder, Rhabdomyosarcoma, Schizophrenia, Scleroderma, Seizures, Squamous cell carcinoma, Status epilepticus, Substance abuse, Systemic sclerosis, DepressionView all (24 more) |
2745
|
|
|
Cannabinoid receptor 2 |
CB-2, CB2, CX5 |
Anterior cruciate ligament injury, Atherosclerosis, Bipolar disorder, Breast neoplasms, Cannabis abuse, Catalepsy, Cholelithiasis, Major depressive disorder, Diarrhea, Disorders involving the immune mechanism, Dysentery, Endometrial neoplasms, Hyperalgesia, Hyperemia, Hyperglycemia, Immune system disease, Inflammatory bowel disease, Myeloid leukemia, Liver cirrhosis, Pancreatic neoplasms, Pancreatitis, Secondary parkinson disease, Post-traumatic stress disorder, Schizophrenia, Scleroderma, Systemic sclerosisView all (11 more) |
2746
|
|
|
Cannabinoid receptor interacting protein 1 |
C2orf32, CRIP-1, CRIP1 |
|
2747
|
|
|
Consortin, connexin sorting protein |
C1orf71, PPP1R64 |
|
2748
|
|
|
Cyclin N-terminal domain containing 1 |
CNTD, COSA1 |
|
2749
|
|
|
Ciliary neurotrophic factor |
HCNTF |
|
2750
|
|
|
Ciliary neurotrophic factor receptor |
- |
|
